Skip to main content
Signal8
Launch Terminal

NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)

NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Neonc Technologies Holdings, Inc. logo

Neonc Technologies Holdings, Inc.

NASDAQ:NTHIHealthcare
+4.49%$3.26
AH$3.12-4.29%vs close
Mkt Cap$93.91M
Float13.35M
O/S28.81M
Vol
$ Vol
RVOL
Inst Own11.0%
SI6.6%
Earnings
Dilution
Neonc Technologies Holdings, Inc. logoNASDAQ:NTHI$3.26+4.49%
FormDescription
8-K
7.01,9.01
3
3
PRIMARY DOCUMENT
8-K
5.02,7.01,9.01
8-K
7.01,9.01
3
8-K
3.03,5.03,7.01,9.01
3
4
PRIMARY DOCUMENT
8-K
7.01,9.01
3
4
PRIMARY DOCUMENT
4
PRIMARY DOCUMENT
4
PRIMARY DOCUMENT
144
Notice of Proposed Sale of Securities
4
PRIMARY DOCUMENT
8-K
1.01,7.01,9.01
6
424B5
Prospectus Supplement
8
8-K/A
5.02
4
PRIMARY DOCUMENT
4/A
PRIMARY DOCUMENT
8-K
5.07
4
PRIMARY DOCUMENT
4
PRIMARY DOCUMENT
4
PRIMARY DOCUMENT
8-K
7.01,9.01
5
8-K
7.01,9.01
5
8-K
2.02,7.01,9.01
5
10-Q
Quarterly Report
8

1-25 of 205

…

Recent SEC filings with analysis